Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06694857Phase 4Completed
Phase 4, open-label, single-arm trial of hyaluronic acid sodium composite gel for injection in facial asymmetry, sponsored by University of Pennsylvania. Primary endpoint: Volume change of the lower face area at 30 days. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06694857.